ONEMEDNET CORPORATION Impairment of Long-Lived Assets to be Disposed of
ONEMEDNET CORPORATION (ONMD) reported Impairment of Long-Lived Assets to be Disposed of of $0 for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-07-08.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2026-07-08
- ONEMEDNET CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2023-12-31 was $0.00.
- ONEMEDNET CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2023-09-30 was $0.00.
- ONEMEDNET CORPORATION impairment of long-lived assets to be disposed of for the quarter ending 2022-12-31 was $0.00.
- ONEMEDNET CORPORATION impairment of long-lived assets to be disposed of for fiscal 2023 was $0.00.
- ONEMEDNET CORPORATION impairment of long-lived assets to be disposed of for fiscal 2022 was $0.00.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 9 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 S-1/A · filed 2026-07-08 | |||
| 2024-12-31 | $0.00 S-1/A · filed 2026-07-08 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 8-K/A 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-20 | $0.00 8-K/A · filed 2024-11-22 | ||
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $0.00 10-K/A · filed 2024-11-05 | ||
| 2022-09-30 | $0.00 8-K/A · filed 2024-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |